HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changing patterns in neonatal respiratory diseases.

Abstract
Using the current Nottingham Health District, England, as a geographically defined population we have investigated the changing patterns of neonatal respiratory diseases. We have categorized all newborns who developed a respiratory problem during either 1977 or between April 1, 1983, and March 31, 1984 using a system based on that of Hjalmarson (Acta Paediatr Scand 1981; 70:773-783). There has been no change in the incidence of any of the disease types. However, the gestation of babies in two groups, idiopathic respiratory distress syndrome (IRDS) and minimal respiratory disturbance (requiring added oxygen for less than 6 hours), has shown a significant reduction. Overall, mortality for infants developing IRDS has shown a slight decrease, and for infants between 29 and 32 weeks gestation, mortality has shown a significant reduction. Overall, requirements for oxygen therapy and ventilation have shown a threefold increase, while hours in receipt of continuous positive airways pressure (CPAP) have increased sevenfold.
AuthorsD J Field, A D Milner, I E Hopkin, R J Madeley
JournalPediatric pulmonology (Pediatr Pulmonol) 1987 Jul-Aug Vol. 3 Issue 4 Pg. 231-5 ISSN: 8755-6863 [Print] United States
PMID3658528 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • England
  • Fetal Organ Maturity
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Lung (embryology)
  • Meconium Aspiration Syndrome (epidemiology)
  • Respiration Disorders (epidemiology)
  • Respiratory Distress Syndrome, Newborn (epidemiology)
  • Respiratory Tract Infections (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: